A series of indoline thiohydantoin derivatives were synthesized and evaluated in vitro. The most potent compound 48c shows comparable ability with enzalutamide in proliferation inhibition of LNCaP cells. Compound 48c has less cytotoxic to AR-negative cells compared with Enzalutamide. The bicalutamide-resistant mechanism was clarified and overcome by compound 48c.